DRB1*15 alleles are the first strong risk factor associated to a CIDP subset, providing additional evidence that anti-NF155+ CIDP patients constitute a differentiated disease within the CIDP syndrome. Here, PMP22 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.